|
The Effect of Morning vs Evening Aerobic Exercise Training on Cardiac Remodeling and Function Improvement in Patients After ST Elevation Myocardial Infarction
RECRUITINGN/ASponsored by RenJi Hospital
Actively Recruiting
PhaseN/A
SponsorRenJi Hospital
Started2024-04-30
Est. completion2028-04-30
Eligibility
Age17 Years – 75 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06385834
Summary
The aim of the study was to intervene in the Aerobic exercise time of patients with STEMI and to explore the optimal exercise time for STEMI patients
Eligibility
Age: 17 Years – 75 YearsHealthy volunteers accepted
Inclusion Criteria: * Between 18 and 75-years-old; * Typical symptoms of acute myocardial infarction within 24 hours, with ST segment elevation of ≥1mm in two consecutive leads on electrocardiogram * After receiving complete revascularization treatment * Cardiac function grading I to II without any other serious complications * Left ventricular ejection fraction \>30% * Compliant with the guidelines of the American College of Cardiology/American Heart Association for participating in cardiac rehabilitation standards * Signed written informed consent. Exclusion Criteria: * Patients with unstable angina * severe symptomatic congestive heart failure detectable myocardial ischemia * valvular disease requiring surgery * severe ventricular arrhythmias * severe concomitant life-threatening diseases such as cancer, and rheumatoid disease * osteoarticular diseases that may affect the exercise process
Conditions2
Heart DiseaseST-segment Elevation Myocardial Infarction (STEMI)
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorRenJi Hospital
Started2024-04-30
Est. completion2028-04-30
Eligibility
Age17 Years – 75 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06385834